Hello Patient raises Series A — building specialized voice AI for healthcare that generic platforms can't replicate
Sep 8, 2025 with Alex Cohen
Key Points
- Hello Patient closes Series A roughly 16 months after launch, built by a team that spent three and a half years at Carbon Health before departing in January 2024.
- The company's multi-agent architecture routes patients between specialized agents mid-conversation, achieving 5-10% failure rates on scheduling that horizontal AI platforms cannot match without months of custom engineering.
- Hello Patient positions itself as vertical software with embedded AI, not an AI product, targeting clinic headcount reduction through appointment scheduling, prescription refills, and patient outreach campaigns.
Summary
Hello Patient, a voice AI company targeting healthcare clinics, has closed its Series A, roughly 16 months after founding. The company was built by a team that spent three and a half years at Carbon Health before leaving in January 2024 and starting Hello Patient that April.
The founding bet is that generic voice AI platforms — the call-center incumbents pitching "no more shitty IVRs" and horizontal players like Sierra — cannot handle the operational complexity of healthcare without years of custom build. Sierra, which recently raised at a $10 billion valuation, integrates cleanly with Shopify-style APIs built for simple queries like order tracking. Healthcare practice management systems offer nothing close to that. Hello Patient's CEO argues that most horizontal players will win some deals, spend nine months building custom software to make them work, and then pivot out of the vertical entirely.
The product
The core use case is fully conversational scheduling — a patient calls in, describes symptoms or a service they want, and the agent books the appointment end-to-end without a phone tree. Behind the scenes, Hello Patient runs a multi-agent architecture where specialized agents handle specific appointment types. A Botox agent handles med spa Botox bookings; if the caller switches to laser hair removal mid-conversation, the system routes to a separate laser hair agent. The patient experiences a single continuous conversation. The failure rate sits at 5–10%, which is acceptable for administrative functions but, as the CEO notes, explains why AI doctors are not coming soon — that margin of error is tolerable for scheduling, not for clinical decisions.
The technical architecture is approximately 70% prompt engineering and 30% code-level business logic, with tool calls for discrete actions like creating appointments, verifying patient identity, and finding available providers. There is no RL training environment; the company relies on foundation models to handle edge cases and constrains agent behavior through structured business logic rather than post-training.
Go-to-market
Hello Patient treats early customer relationships as partnerships, reflecting how early the market is. The pitch to clinics is straightforward: if the agent can reliably schedule appointments, refill prescriptions, and run outbound campaigns reminding patients they're overdue for annual visits or vaccines, the front desk doesn't have to. Clinics don't particularly care that the technology is AI — they care that it's cheaper, faster, and reduces headcount requirements.
The longer-term roadmap goes deeper into clinic software beyond the AI interface, building tools to help clinic staff do their jobs more efficiently when the AI isn't handling the call directly. The framing is vertical software with AI deeply embedded, not an AI product that happens to touch healthcare.